MAPT and Alzheimer disease: As one of the most common neurodegenerative disorders in the world, AD is characterized by amyloid β (amyloid β, Aβ) plaques and neurofibrillary tangles of hyperphosphorylated tau protein, which are often accompanied by region-specific cerebral atrophy and a significant decrease in glucose metabolic utilization (1).